ESR1 and Parkinson disease: Raloxifene is a selective estrogen receptor modulator (SERM) prescribed for osteoporosis treatment, and was recently suggested for repurposing in PD following studies showing the neuroprotective and anti-inflammatory activity of this drug in the MPTP mouse model of PD (Bourque et al., 2014; Poirier et al., 2016).